| Article | Added |
|---|
| Siegfried Outsources Support Functions | 07-30-10 |
| Stellar Pharmaceuticals Inc. Signs Agreement With Laboratorios Inibsa, S.A. for Distribution and Sale of Uracyst(R) in Spain | 07-30-10 |
| WuXi AppTec, Inc.??'s CEO Blames Short-Term Financial Concerns for Merger's Demise | 07-30-10 |
| Curaxis Pharmaceutical Corp. Announces Completion of Reverse Merger With | 07-30-10 |
| Ruling May Force Cody Laboratories, Inc. To Halt Making Morphine; May Have To Lay Off Some 50 Workers | 07-30-10 |
| Laxai Pharma Ltd. and UTA Capital LLC Agree to Extend Term of $1.44 Million Term Loan and Reduce Its Interest Rate
| 07-30-10 |
| MediStem, Inc. (Formerly known as Medistem Laboratories, Inc.) Release: Protein Found on Stem Cells Protects Against Immune Attack | 07-30-10 |
| Data On Basilea Pharmaceutica's Toctino(R) In Daily Medical Practice In Germany Presented At Congress | 07-30-10 |
| Curaxis Pharmaceutical Corp. Announces Completion of Reverse Merger With Auto Search Cars, Inc. | 07-30-10 |
| Radient Pharmaceuticals Reveals New Divestiture Plan for China Subsidiary | 07-30-10 |
| Idaho Technology Inc. Issues License to DuPont Qualicon | 07-30-10 |
| Number of Shares and votes in Active Biotech AB | 07-30-10 |
| Geron Corporation to Proceed with First Human Clinical Trial of Embryonic Stem Cell-Based Therapy | 07-30-10 |
| Actient Pharmaceuticals LLC Closes Transaction to License and Acquire Specialty Pharmaceutical Products from UCB, Inc. | 07-30-10 |
| Stellar Pharmaceuticals Inc. Signs Agreement With for Distribution and Sale of Uracyst(R) in Spain | 07-30-10 |
| Lpath, Inc. Receives $3 Million Grant From the National Eye Institute | 07-30-10 |
| Novartis Vaccines & Diagnostics, Inc. Begins Shipment of Seasonal Influenza Vaccine Fluvirin(R) to U.S. Market to Help Protect Ahead of 2010-2011 Flu Season | 07-30-10 |
| PPD, Inc. Expands cGMP Laboratory Services in North America | 07-30-10 |
| Clinical and Laboratory Standards Institute Showcases StatisPro(TM) | 07-30-10 |
| Abaxis, Inc. Reports Record Revenues for the First Quarter of Fiscal 2011 | 07-30-10 |
| Amgen's Second Quarter 2010 Adjusted Earnings Per Share Increased 7 Percent to $1.38 | 07-30-10 |
| BioSpecifics Technologies Corporation to Host Conference Call to Report Second Quarter 2010 Financial Results on August 6, 2010 | 07-30-10 |
| Biodel Inc. to Report Third Quarter Fiscal Year 2010 Financial Results on August 5, 2010 | 07-30-10 |
| Australian Watchdog Clears Novartis AG Bid For Alcon, Inc. | 07-30-10 |
| Angiotech Pharmaceuticals, Inc. Loss Widens As Royalties Slow | 07-30-10 |
| Mylan Inc. Announces Proposed Add-On Private Placement of its Senior Notes Due 2020 | 07-30-10 |
| Actient Pharmaceuticals LLC Inks Deal with UCB SA for Marketed Drugs with Global Sales of $53M | 07-30-10 |
| Orexigen Therapeutics, Inc. Obesity Pill Shows Promise in Phase III Study; Stock Rises 11.37% at 10:17AM EDT | 07-30-10 |
| FDA Warns About Pneumonia Caused By Cubist Pharmaceuticals, Inc.'s Antibiotic Cubicin | 07-30-10 |
| Ruling May Force To Halt Making Morphine; May Have To Lay Off Some 50 Workers | 07-30-10 |
| Anacor Pharmaceuticals, Inc. to Receive $15 million payment from Glaxo | 07-30-10 |
| CT Atlantic AG Announces Appointment of Michael Hocker To CEO | 07-29-10 |
| Optimer Pharmaceuticals, Inc. Submits Fidaxomicin Marketing Authorization Application for the Treatment of Clostridium difficile Infection | 07-29-10 |
| BioNovo, Inc. to Advance Menerba to Phase 3 Clinical Testing in Europe | 07-29-10 |
| Anadys Pharmaceuticals, Inc.: ANA598 Demonstrates SVR12 in 100% of First Group of HCV Patients Randomized to Stop All Treatment at Week 24 | 07-29-10 |
| Abraxis BioScience, Inc. and Announce Approval to Market ABRAXANE for Metastatic Breast Cancer in New Zealand | 07-29-10 |
| VaxGen, Inc. and diaDexus Complete Merger | 07-29-10 |
| The New England Journal of Medicine Publishes Data from Dendreon Corporation's Pivotal Phase 3 PROVENGE IMPACT Study | 07-29-10 |
| Marina Biotech, Inc. (Formerly Known as MDRNA, Inc.) Announces Upcoming Investor Conference Presentations | 07-29-10 |
| Eli Lilly and Company Loses Appeal in Gemzar Patent Case | 07-29-10 |
| Sanofi-Aventis (France) Q2 Net up 61 Percent | 07-29-10 |
| CMP Therapeutics Appoints Dr. Neill Moray Mackenzie as CEO | 07-29-10 |
| Grifols H1 Sales Meet Forecasts, Net Profit Misses | 07-29-10 |
| Talecris Biotherapeutics Q2 Profit Beats Street | 07-29-10 |
| Celgene Earnings Top Expectations, Shares Jump | 07-29-10 |
| BioSpace Showcases the Midwest's Growing Life Science Region | 07-29-10 |
| UK's Recommends Roche Holding AG's MabThera For Leukemia | 07-28-10 |
| Bausch & Lomb Recall of PreserVision Eye Vitamin in the United States | 07-28-10 |
| Advanced Life Sciences Holdings, Inc. Applies for FDA Fast-Track Designation for Restanza in CABP | 07-28-10 |
| Topaz Pharmaceuticals Announces Positive Data from Topical Ivermectin Trials Presented at | 07-28-10 |
| ArQule, Inc. Announces Initiation by Kyowa Hakko Kirin of Phase 2 Clinical Trial in Asia with ARQ 197 in Gastric Cancer | 07-28-10 |
| Pharmasset, Inc. Initiates Phase 1b Multiple Ascending Dose Clinical Trial of PSI-938 in Patients with Chronic Hepatitis C | 07-28-10 |
| Limerick BioPharma Inc. Announces Positive Phase 1b Data for LIM-0705 in Preventing Toxicities Associated with the Transplant Drug, Tacrolimus | 07-28-10 |
| DiaMedica Inc. Announces Autoimmune Program With Positive Rheumatoid Arthritis Results | 07-28-10 |
| EpiCept Corporation Amends Employment Agreement and Completes Severance Agreements with Executive Officers | 07-28-10 |
| Illumina, Inc. Announces Creation of the Genome Network | 07-28-10 |
| Mylan Inc. Plans Eur 67 Million Solid-Dose Packaging Plant in Hungary | 07-28-10 |
| Allos Therapeutics, Inc. Announces Topline Results from Phase 2b Study of FOLOTYN in Patients with Advanced Non-Small Cell Lung Cancer | 07-28-10 |
| Covidien Completes Acquisition of Somanetics | 07-28-10 |
| Merck & Co., Inc. Grants License to Laboratory Corporation of America Holdings (LabCorp) for Development of Test To Potentially Identify Patients Likely to Respond to Hepatitis C Therapy | 07-28-10 |
| Merck & Co., Inc. Pays Settlements in 3,468 Vioxx Cases | 07-28-10 |
| Commonwealth Biotechnologies, Inc. Announces Appointment of as Chief Executive Officer | 07-27-10 |
| INC Research, Inc. Signs 3 Year GrantPlan(R) Agreement With to Reduce Investigator Grant Development Time and Increase Overall Efficiency | 07-27-10 |
| Antigenics Inc. (Lexington, MA) Presents Positive, Top Line Data from Phase I Herpes Clinical Trial | 07-27-10 |
| Omeros Corporation Enrolls First Patient in Phase 2b Clinical Trial Evaluating OMS302 in Patients Undergoing Cataract Surgery | 07-27-10 |
| Dynavax Technologies Corporation Completes Enrollment and First Immunizations in Universal Flu Vaccine Study | 07-27-10 |
| Roche Results: Results from Two Multi-Site Collaborative Studies Highlight the Value of 454 Sequencing Systems for Genotyping Applications | 07-27-10 |
| Sanofi-Aventis (France) and Merck & Co., Inc. Appoint as CEO for the New Animal Health Joint Venture | 07-27-10 |
| Novartis Corporation Q2 Prompts Fresh Call for Higher Alcon, Inc. Bid | 07-27-10 |
| Regado Biosciences Announces Publication in the American Heart Association Journal of the Results of a Phase 2a Study for the REG1 Anticoagulant System in Elective Percutaneous Interventions | 07-27-10 |
| Synta Pharmaceuticals Announces STA-9090 Results Published in Journal Demonstrating Potent In Vitro and In Vivo Activity in AML | 07-27-10 |
| Peer-Reviewed Journal Publishes Findings by Viral Genetics Inc. Lead Scientist | 07-27-10 |
| Appeal Ruling Forces Rethink on Celgene's Vidaza for MDS | 07-27-10 |
| Bio Nano Consulting Signs Agreement With The School Of Pharmacy, University of London And Clinches First Phase 1 Cancer Drug Formulation Contract | 07-27-10 |
| QRxPharma Pty Ltd. Receives Positive Feedback from Scientific Advice Meetings in Europe on MoxDuo(R)IR Development and Registration | 07-26-10 |
| Sequella, Inc.: Two New Tuberculosis (TB) Drugs Show Significant Synergy In Vitro | 07-26-10 |
| Hospira, Inc. Begins Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients | 07-26-10 |
| Tibotec Pharmaceuticals Ltd Submits New Drug Application for Investigational Once-Daily HIV Treatment TMC278 to U.S. FDA | 07-26-10 |
| Onyx Pharmaceuticals, Inc. Announces a Teleconference and Webcast to Provide a Clinical Update on Carfilzomib | 07-26-10 |
| FDA Approves Sandoz, Inc.'s First Generic Enoxaparin Sodium Injection | 07-26-10 |
| Perrigo Company Announces FDA Approval for Over-the-Counter Cetirizine Cherry Syrup | 07-26-10 |
| European Committee for Medicinal Products for Human Use (CHMP) Adopts Positive Opinion for TWYNSTA(R), Boehringer Ingelheim Corporation??'s New Single Pill Combination Hypertension Treatment | 07-26-10 |
| Asuragen, Inc. and Collaborators Report Results Using PCR-Only Technologies for the Comprehensive Molecular Assessment of the Fragile X Gene | 07-26-10 |
| NovImmune SA Enters Exclusive Antibody Licensing Agreement with Genentech | 07-26-10 |
| Can-Fite BioPharma Drug Candidate CF102 Significantly Decreased Viral Load of HCV in 3 Patients with Liver Cancer | 07-26-10 |
| Gilead Sciences, Inc. to Offer $2.2 Billion of Convertible Senior Notes; Company to Repurchase $1 Billion in Common Stock | 07-26-10 |
| XenoPort, Inc. Announces Presentation of Preclinical Data for Acamprosate Prodrug at Syndrome Conference | 07-23-10 |
| Federal Government Seizes Cyanide Antidote Kits From California Company, Keystone Pharmaceuticals, Inc. | 07-23-10 |
| Teva Pharmaceutical Industries Limited Comments on Generic Lovenox(R) Approval | 07-23-10 |
| BHR Pharma, LLC Enrolls First Patient in Phase 3 SyNAPSe Traumatic Brain Injury Trial | 07-23-10 |
| Genticel??'s Therapeutic Vaccine, Procervix, Aimed At Preventing Cervical Cancer In Patients Already Infected By Human Papillomavirus (HPV), Receives Clearance To Start A Phase I Clinical Trial | 07-23-10 |
| TiGenix Transparency Information | 07-23-10 |
| Mettler-Toledo Reports Second Quarter 2010 Results | 07-23-10 |
| MiMedx Announces Second Quarter Results | 07-23-10 |
| Cornerstone Therapeutics Inc. to Host Second Quarter 2010 Conference Call | 07-22-10 |
| Unigene Laboratories, Inc. Notes Progress of Tarsa Therapeutics Phase III ORACAL Trial of its Oral Calcitonin for the Treatment of Postmenopausal Osteoporosis | 07-23-10 |
| Inhibitex, Inc. Reports Independent Data Safety Monitoring Board Recommends Continuation of Phase II Clinical Trial of FV-100 | 07-23-10 |
| Abraxis BioScience, Inc.'s ABRAXANE(R) Approved for Marketing in Japan for Breast Cancer | 07-23-10 |
| Four Rivers Software Systems Announces TMS Anywhere | 07-22-10 |
| Momenta Pharmaceuticals, Inc. Announces FDA Approval for First Generic Lovenox(R); Shares Surge | 07-23-10 |
| Advanced Life Sciences Holdings, Inc. CEO Acquires $2 Million of Common Stock Through Debt for Equity Exchange | 07-23-10 |
| Anadys Pharmaceuticals, Inc. to Report Second Quarter 2010 Financial Results | 07-23-10 |
| Human Genome Sciences, Inc. Announces Second Quarter 2010 Financial Results and Key Developments | 07-23-10 |
| IDEXX Laboratories, Inc. Announces Second Quarter Results | 07-23-10 |
| Mylan Inc. Reschedules Second Quarter Earnings Call for Wednesday July 28, at 5 p.m. ET | 07-23-10 |
| Federal Government Seizes Cyanide Antidote Kits From California Company, | 07-23-10 |
| BHR Pharma Enrolls First Patient in Phase 3 SyNAPSe Traumatic Brain Injury Trial | 07-23-10 |
| IMPAX Laboratories, Inc. Receives Final FDA Approval for Generic OPANA(R) ER Tablets | 07-23-10 |
| Poniard Pharmaceuticals, Inc. Receives Deficiency Notice Related to Minimum Bid Price | 07-23-10 |
| Mylan Laboratories Inc. Launches the Generic Version of Solodyn(R), 45 mg, 90 mg and 135 mg Tablets, Announces Settlement Agreement with Medicis | 07-23-10 |
| Theravance, Inc. Reports Second Quarter 2010 Financial Results | 07-23-10 |
| Dynavax Technologies Corporation Appoints to Board of Directors | 07-23-10 |
| Forest Laboratories, Inc., Merz Pharma GmbH & Co. KGaA Settle Patent Dispute Over Namenda | 07-23-10 |
| PRA International, Inc. to Hire 100 to 150 Clinical Research Associates and Project Managers | 07-23-10 |
| Somaxon Pharmaceuticals, Inc. Announces Acceptance of Phase 3 Clinical Trial Data for Publication in Sleep and Sleep Medicine | 07-22-10 |
| EKR Therapeutics, Inc. Names New Chief Executive Officer | 07-22-10 |
| NicOx SA Says Key Drug, Naproxcinod Rejected by FDA; Stock Down 21.07% at 11:35AM EDT | 07-22-10 |
| NPS Pharmaceuticals, Inc. Announces Completion of Patient Randomization in Phase 3 STEPS Study of GATTEX(R) In Short Bowel Syndrome | 07-22-10 |
| Merrimack Pharmaceuticals Inc. and Sanofi-Aventis (France) Initiate Enrollment in a Phase 2 Combination Study of MM-121 and exemestane in Breast Cancer | 07-22-10 |
| CytRx Corporation??'s Tamibarotene Eradicates Cancer in Advanced Acute Promyelocytic Leukemia After Failure of Other Therapies | 07-22-10 |
| MabVax Therapeutics, Inc. Initiates Phase II Clinical Trial of Vaccine to Prevent Recurrent Sarcoma | 07-22-10 |
| Ampio Pharmaceuticals, Inc. Announces Initiation of Phase II Clinical Trial of Optina(TM) | 07-22-10 |
| Antigenics Inc. (Lexington, MA) Receives Delisting Notification | 07-22-10 |
| Covidien plc Declares Quarterly Cash Dividend | 07-22-10 |
| Neovacs SA Achieves Key Clinical Milestones in Trials for Lupus & Arthritis | 07-21-10 |
| Neovasc Inc. Achieves Key Clinical Milestones in Trials for Lupus & Arthritis | 07-21-10 |
| Reckitt Benckiser Plc Agrees to Buy Condom Firm for $3.8 Billion | 07-21-10 |
| Tamir Biotechnology, Inc. (Formerly Known as Alfacell Corporation) Reports Positive Effect Against SARS Virus | 07-21-10 |
| Microarrays, Inc., Purchased From Vanderbilt University By Management Team And Investors | 07-21-10 |
| GE Global Research Launches Study to Improve Diagnosis of Early Stage Colon Cancer | 07-21-10 |
| HighRes Biosolutions Announces Chinese Distributor Agreement with | 07-21-10 |
| Onyx Pharmaceuticals, Inc. Initiates a Phase 3 Carfilzomib Combination Trial in Relapsed Multiple Myeloma | 07-21-10 |
| Albany Molecular Research, Inc. (AMRI) Announces Phase I Study of Novel Drug for Obesity Treatment | 07-21-10 |
| SIDMAP Technology Used to Characterize Novel Drug for Type 2 Diabetes | 07-21-10 |
| Ariad Pharmaceuticals, Inc. to Webcast Conference Call on Second Quarter 2010 Financial Results | 07-21-10 |
| Gilead Sciences, Inc. Announces Second Quarter 2010 Financial Results | 07-21-10 |
| Osiris Therapeutics, Inc. Release: Prochymal New Drug Submission Granted Priority Review by Health Canada | 07-21-10 |
| Two Industry Leaders - Proliant Inc. and Lampire Biological Laboratories, Inc. - Form Strategic Partnership to Provide Bovine Serum Albumin | 07-21-10 |
| BioMimetic Therapeutics, Inc. Announces Closing of Public Offering and Exercise of Over-Allotment Option | 07-21-10 |
| Schwartz Joins Biotechnology Industry Organization (BIO) and Pennsylvania Bio to Discuss the Importance of the Therapeutic Tax Credit for Small Biotech Firms | 07-21-10 |
| Genentech Provides Update From Avastin Genentech Advisory Committee Meeting | 07-21-10 |
| Eli Lilly and Company Pays up to $380M for Alnara Pharmaceuticals, Inc. | 07-21-10 |
| Mettler-Toledo Release: Fast, Reproducible Synthesis Reduces Research Costs: EasyMax | 07-21-10 |
| Lawrence Bruder Joins Noxilizer as President & Chief Executive Officer | 07-20-10 |
| Winston Laboratories, Inc. Receives Notice of Compliance in Canada for CIVANEX(TM) (Civamide Cream) for Treatment of Osteoarthritis | 07-20-10 |
| KAI Pharmaceuticals, Inc. Announces Phase 1 Results of KAI-4169 for the Treatment of Secondary Hyperparathyroidism (SHPT) | 07-20-10 |
| Sanofi-Aventis (France) Receives Clearance for Acquisition | 07-20-10 |
| Neogen Corporation Reports 26% Increase in Net Income | 07-20-10 |
| New Could Create 4,800 Jobs | 07-20-10 |
| Forbes Medi-Tech Inc. Receives Acquisition Proposal From Pharmachem Laboratories, Inc. | 07-20-10 |
| Alnylam Pharmaceuticals to Webcast Virtual RNAi Roundtable on ALN-TTR for Treatment of Transthyretin-Mediated Amyloidosis | 07-20-10 |
| Seattle Genetics, Inc. and Agensys, Inc., an Affiliate of Astellas Pharma Inc., Announce Initiation of Phase I Clinical Trial of ASG-5ME for Pancreatic Cancer | 07-20-10 |
| Cubist Pharmaceuticals, Inc. to Ring the NASDAQ Stock Market Opening Bell | 07-20-10 |
| ZIOPHARM Oncology, Inc. to Initiate Phase 3 Study for Sarcoma Connective Tissue Cancer | 07-20-10 |
| The Indian Drugs Controller General Approves Start of Clinical Study of Hemispherx Biopharma's Natural Interferon Product, Alferon N Injection(R), in Hospitalized Flu Patients | 07-19-10 |
| Eisai Inc. Release: FDA Accepts BANZEL(R) (Rufinamide) Oral Suspension NDA for Review | 07-19-10 |
| Aoxing Pharmaceutical Company Inc. Reports Enrollment Progress on Phase III Clinical Trial of TJSL Capsules | 07-19-10 |
| Amira Pharmaceuticals, Inc. Hits Two Development Milestones Related to FLAP Inhibitor Program | 07-19-10 |
| Pfizer Inc.'s Coxib Triggers Fewer Lower GI Events Than NSAID + PPI | 07-19-10 |
| Azathioprine Adds Nothing in IgA Nephropathy, Researchers Report in the | 07-19-10 |
| Tobira Therapeutics Inc.'s Next-Generation Once-Daily CCR5/CCR2 Antagonist Demonstrates Potent CCR2 Inhibition, Antiviral Activity, Safety and Tolerability in Treatment-Experienced Patients With HIV | 07-19-10 |
| Argos Therapeutics, Inc.' Arcelis(TM) HIV Immunotherapy Demonstrates Significant Reduction in Viral Load and Delay in Viral Rebound Kinetics in Interim Analysis of Phase 2 Study | 07-19-10 |
| Mylan Inc. Receives Approval for Generic Version of Catapres-TTS(R) | 07-19-10 |
| FDA Grants Priority Review Designation to Amgen's Denosumab Biologics License Application for the Reduction of Skeletal Related Events in Advanced Cancer Patients | 07-19-10 |
| PriCara???, Ortho-McNeil-Janssen Pharmaceuticals, Inc.: Phase 3 Open-Label Study Comparing Tapentadol Extended Release Tablets to Oxycodone Controlled Release Tablets Published by | 07-19-10 |
| Sun Pharmaceutical Industries Ltd Says U.S. Court Denies Motion on Protonix | 07-19-10 |
| Puppet Labs Raises $5 Million | 07-19-10 |
| TARIS Biomedical Appoints as President and CEO | 07-19-10 |
| Steve Andrzejewski Joins Nycomed US Inc. as New CEO | 07-19-10 |
| Baltimore Facility Key to Emergent BioSolutions' Plan to Expand Beyond Biodefense | 07-19-10 |
| Threshold Pharmaceuticals, Inc. Presents Preclinical Results in Two Scientific Presentations at American Association for Cancer Research Translational Cancer Medicine Meeting | 07-16-10 |
| Epizyme Scientists Detail Epigenetic Approaches to Cancer Therapy in Therapeutic Strategies and | 07-16-10 |
| AVI BioPharma, Inc. Announces Presentations on Exon Skipping Drug AVI-4658 for Treatment of Duchenne Muscular Dystrophy at | 07-16-10 |
| Sun Pharmaceutical Industries Ltd Announces US FDA Approval for Generic Flomax(R) | 07-16-10 |
| Sun Pharmaceutical Industries Ltd Announces US Sun Pharmaceutical Industries Ltd Approval for Generic Flomax(R) | 07-16-10 |
| Childrens Hospital Los Angeles Partners in $56.8 Million Childrens Hospital Los Angeles Award for Clinical and Translational Research | 07-16-10 |
| BioFocus DPI And University of Bristol Enter Drug Discovery Collaboration In Chronic Pain
| 07-16-10 |
| T-Ray Science Announces Results of Annual General Meeting | 07-16-10 |
| Sales Revenue Exceeds Projections, BDI Pharma, Inc. (Formerly known as Blood Diagnostics, Inc.) Demonstrates Continued Growth | 07-16-10 |
| GTC Biotherapeutics Regains US Rights to ATryn(R); the First Recombinant Antithrombin Product Approved in the World | 07-16-10 |
| Mayo Clinic Health Letter Highlights MicroRNA -- A Switch that Determines Cell Behavior and Holds Answers on Disease, Prevention, And Treatment | 07-16-10 |
| Leading Diabetes Management Company, Insulet Corporation, Goes Live with Pilgrim Software's On-Demand CAPA Management | 07-16-10 |
| Cubist Pharmaceuticals, Inc. 2Q10 Total Net Revenues Up 29% to $168.5 Million | 07-16-10 |
| FDA Panel Rejects VIVUS, Inc. Diet Drug | 07-16-10 |
| Starpharma Holdings Ltd Receives FDA Clearance To Commence Phase 2 Bacterial Vaginosis Study For Vivagel(R) | 07-15-10 |
| Hemispherx Biopharma Publishes Full Report of Three Year Joint Research Program at Japanese | 07-15-10 |
| Intellect Neurosciences, Inc. Encouraged by Clinical Trial Data in Relation to Its Alzheimer's Immunotherapy Patents and Technology | 07-15-10 |
| Nitric BioTherapeutics Initiates Phase II Onychomycosis Study | 07-15-10 |
| Provectus Pharmaceuticals Inc. Reports Achieved Milestones for First Half of 2010, Recent Developments and Plans for the Remainder of the Year to Shareholders | 07-15-10 |
| Noscira Presents Results of Phase IIa Clinical Trial with Nypta(R) (Tideglusib) on Alzheimer's Disease at International Conference on Alzheimer's Disease (ICAD) | 07-15-10 |
| Geron Corporation Provides Update on Telomerase Activation Program | 07-15-10 |
| Peregrine Pharmaceuticals, Inc. 4Q Loss Widens; Lower Revenue, Higher Costs | 07-15-10 |
| Merck KGaA, Darmstadt, Germany Completes Millipore Corporation Acquisition and Launches New (Outside U.S. and Canada) | 07-15-10 |
| Elusys Therapeutics, Inc. and Lonza Group Ltd. Extend Manufacturing Agreement for Anthim, a New Anthrax Treatment in Late-Stage Development | 07-15-10 |
| Alchemia and Dr. Reddy's Laboratories Ltd. Expand Fondaparinux Marketing Collaboration | 07-15-10 |
| Allozyne, Inc. Fortifies Its Proprietary Position With A License For Click Chemistry, a Bioconjugation Enabling Cycloaddition Technology From The Scripps Research Institute | 07-15-10 |
| FDA Panel Recommends Keeping GlaxoSmithKline's Avandia On US Market, But With More Warnings, Restrictions | 07-15-10 |
| Molecular Insight Pharmaceuticals, Inc.'s Zemiva Phase 2 Data Published in Journal of the American College of Cardiology | 07-14-10 |
| FDA Panel Recommends Keeping GlaxoSmithKline's Avandia On US Market | 07-15-10 |
| Bristol-Myers Squibb Company Release: Recall of Coumadin 1 mg Tablet Blister Packs | 07-14-10 |
| Sanofi-Aventis (France) And Novalar Pharmaceuticals, Inc. File Marketing Authorization Application for OraVerse(R) in Five Key European Countries | 07-14-10 |
| Peregrine Pharmaceuticals, Inc. Initiates Second Randomized Phase IIb Lung Cancer Trial Using First-In-Class PS-Targeting Monoclonal Antibody Bavituximab | 07-14-10 |
| Eden Biodesign Assists to Commence Human Clinical Trials Less Than 12 Months After Being Engaged to Produce a Recombinant Adenovirus Vector from a New Cell Line | 07-14-10 |
| Invida Announces Alliance with Amdipharm | 07-14-10 |
| ChemGenex Pharmaceuticals Limited and U.S. FDA Agree on Potential Regulatory Pathway for OMAPRO(TM) | 07-14-10 |
| Nabi Biopharmaceuticals Completes Enrollment of First NicVAX Phase III Clinical Trial | 07-14-10 |
| Cubist Pharmaceuticals, Inc. Announces Objectives Met in Phase 2 Safety Study of CUBICIN in Prosthetic Joint Infections | 07-14-10 |
| Aastrom Biosciences, Inc. Initiates IMPACT-DCM Extension Study for Control Patients | 07-14-10 |
| HemoShear, LLC Scientists Profile Genomic Behavior of the Human Artery | 07-14-10 |
| PPD, Inc. and Lovelace Respiratory Research Institute Enter into Collaboration for Laboratory, Preclinical and Clinical Research Services | 07-14-10 |
| OSI Pharmaceuticals, Inc. Announces the Results of its Offer to Purchase its 2% Convertible Notes and a Change in the Expiration Time of its Offer to Purchase its 3% Convertible Notes | 07-14-10 |
| Vertex Pharmaceuticals (MA) Appoints To Its Board of Directors | 07-14-10 |
| Kymab And Wellcome Trust Sign ??20 Million Financing To Build A UK Biopharmaceutical Company Based On Human Monoclonal Antibody Technology From The Sanger Institute | 07-13-10 |
| EntreMed, Inc.'s ENMD-2076 Demonstrates Significant Anti-Cancer Activity in Multiple Myeloma Preclinical Models | 07-13-10 |
| EDP Announces Single Injection of New Insulin Maintains Tight Glucose Control for 140 Days | 07-13-10 |
| Baxter International, Inc. Release: Real-World Experience Confirms Low Inhibitor Rate Established in ADVATE Controlled Clinical Studies for Hemophilia Patients | 07-13-10 |
| Biodel Inc. Reports Progress with Development of Glucose-Regulated 'Smart' Basal Insulin | 07-13-10 |
| K-V Pharmaceutical Announces Resubmission to New Drug Application for Gestiva(TM) | 07-13-10 |
| MAP Pharmaceuticals, Inc. Announces Results from LEVADEX Pharmacokinetics Trial in Smokers | 07-13-10 |
| Innocoll, Inc. Submits SPA for Cogenzia(TM) Phase III Clinical Trials for the Adjuvant Treatment of Diabetic Foot Infections | 07-13-10 |
| A5 Labs Completes Acquisition of CRO Assets and Interferon Production Technology | 07-13-10 |
| Forbes Medi-Tech Inc. Announces the Sale of Its Reducol(TM) Business to an Affiliate of Marco Hi-Tech JV, Ltd. | 07-13-10 |
| Radient Pharmaceuticals Enters Into a Letter of Intent to Acquire Provista Diagnostics (PDx) | 07-13-10 |
| GLG Life Tech Corporation Announces Distribution Agreement Signed With | 07-13-10 |
| RXi Pharmaceuticals Awarded National Institutes of Health (NIH) Grant to Advance RNAi Therapeutics | 07-13-10 |
| Miraculins Inc. Announces Issuance of Important Preeclampsia Patent in United States | 07-13-10 |
| Clinuvel Release: Successful Drug Trial Results for Light Intolerant 'Shadow Jumpers' | 07-13-10 |
| BioSante Pharmaceuticals, Inc. Announces Initiation of LibiGel(R) Study to Evaluate its Effect on Cognitive Function in Women | 07-13-10 |
| iBio, Inc. Institute to Present Biotech TalentSparks Teacher Workshop | 07-13-10 |
| Human Genome Sciences, Inc. and Lonza Inc. Enter Commercial Manufacturing Agreement for BENLYSTA(R), a Potential New Treatment for Systemic Lupus Erythematosus | 07-13-10 |
| Cegedim Dendrite Launches New Version of State Guardian(TM), Renames Software AggregateSpend360(TM) | 07-12-10 |
| CEA-Leti Building A Complete 300mm R&D Line Dedicated to 3D-Integration Applications | 07-12-10 |
| ESI Releases Virtual Performance Solution 2010 | 07-12-10 |
| China VC Firm Leads Series B Financing for | 07-12-10 |
| AmpliMed Corporation Reports Results from AMP-019; A Randomized Double Blind Trial of Gemcitabine/Placebo vs. Gemcitabine/Amplimexon in Advanced Pancreatic Cancer | 07-12-10 |
| Medivir AB Announces Phase 2b 24-week Interim Results of TMC435 in Treatment-naive Patients Chronically Infected with Genotype-1 Hepatitis C Virus | 07-12-10 |
| Mesoblast Limited Phase 3 Meeting Scheduled With FDA Following Positive Results Of Bone Marrow Regeneration Trial | 07-12-10 |
| ProCure Proton Therapy Center Celebrates One Year Anniversary | 07-09-10 |
| Pharmaceutical Care Management Association Release: Top Federal Appeals Court Strikes Down D.C.'s Controversial PBM Fiduciary Law | 07-09-10 |
| KAEL???GemVax Reports Significant Interim Progress In UK Telovac Phase III Study Of GV1001 Anti-Telomerase Vaccine In Pancreatic Cancer | 07-12-10 |
| Novelos Therapeutics, Inc. Announces Positive Phase 2 Results in NOV-002 Neoadjuvant Breast Cancer Trial at at the University of Miami | 07-12-10 |
| Bristol-Myers Squibb Company And Otsuka Pharmaceutical Co., Ltd. Release: SPRYCEL(R) (dasatinib) Receives FDA Priority Review for the Treatment of Adult Patients with Newly Diagnosed Chronic Myeloid Leukemia (CML) in Chronic Phase | 07-12-10 |
| Pacific Biosciences Launches Software Developer's Network | 07-09-10 |
| Johnson & Johnson Sued for Fraud Over Pediatric Drug Recall | 07-12-10 |
| Synthetic Genomics, Inc.-ExxonMobil Research and Engineering Company Media Advisory | 07-12-10 |
| Bristol-Myers Squibb Company Release: SPRYCEL(R) (dasatinib) Receives FDA Priority Review for the Treatment of Adult Patients with Newly Diagnosed Chronic Myeloid Leukemia (CML) in Chronic Phase | 07-12-10 |
| Immunacia's Genetic Immunity Presents DermaVir at the 7th International Conference on Nanosciences & Nanotechnologies ??? A Unique Nanomedicine for Therapeutic HIV Vaccine | 07-12-10 |
| Biogen Idec, Inc. (Massachusetts) and Swedish Orphan Biovitrum Present Data on Long-Lasting Hemophilia B Therapy at the Congress | 07-12-10 |
| HanAll BioPharma Co., Ltd. Release: U.S. IND Accepted by the FDA in Support of the Clinical Development HL 007, a Unique Fixed Dose Combination to Treat Cardiovascular Disease | 07-12-10 |
| Athenahealth Achieves Preliminary Interim Final Rule (IFR) Stage 1 EHR Certification from CCHIT | 07-09-10 |
| Ikaria Inc. Names New Chief Financial Officer | 07-09-10 |
| 11 French High-Tech Organizations to Present Latest Technologies At SEMICON West | 07-09-10 |
| New Publication Highlights Early Potential Of Novartis Corporation QTI571 (Imatinib) In Severe Pulmonary Arterial Hypertension (PAH)
| 07-09-10 |
| Graceway Pharmaceuticals, LLC Release: New Data Demonstrate Zyclara(TM) Imiquimod 3.75% Superior to Placebo for Treatment of External Genital Warts (EGW) | 07-09-10 |
| Sysmex America, Inc. Announces Amerinet, Inc. Urinalysis Contract | 07-09-10 |
| Adimab, Inc. Announces Fifth Major Pharmaceutical Partnership in First Year After Launch of Novel Antibody Discovery Platform | 07-09-10 |
| AtCor Medical Pty Ltd Announces New $1.77 Million Pharmaceutical Clinical Trials Contract | 07-09-10 |
| MediGene AG Appointed Exclusive Greek Licensee for Personalized Prescribing Software | 07-09-10 |
| Biogen, Inc. and Swedish Orphan Biovitrum Announce Decision to Advance Long-Lasting Hemophilia A Therapy into a Registrational Trial | 07-09-10 |
| Biogen Idec, Inc. (North Carolina) and Swedish Orphan Biovitrum AB Announce Decision to Advance Long- Lasting Hemophilia A Therapy into a Registrational Trial | 07-09-10 |
| Pfizer Inc. to Present More Than 40 Abstracts on Pre-Clinical, Clinical and Outcomes Research at International Conference on Alzheimer's Disease | 07-09-10 |
| Helix BioMedix, Inc. Acquires Ownership Interest in Skincare | 07-09-10 |
| Rockwell Medical Technologies Successfully Completes FDA Meeting Regarding SFP | 07-08-10 |
| Advanced Life Sciences Holdings, Inc. Announces Successful Preclinical Data Supporting Restanza Intravenous Formulation for Hospital Use | 07-08-10 |
| Endotis Pharma Presents Phase I Clinical Trial Results For A First-In-Class Synthetic Parenteral Neutralizable Anticoagulant EP217609 At The 21st International Congress On Thrombosis | 07-08-10 |
| DiaMedica Inc. Initiates Type 1 Diabetes Study; Announces Preliminary Results | 07-08-10 |
| Insight on MediciNova, Inc.'s MN-166 Mechanism of Action Reported in PNAS | 07-08-10 |
| BioCurex Inc. Announces Positive First Results for Monitoring Cancer Therapy Using Its RECAF Blood Test | 07-08-10 |
| pSivida Corp Announces Submission of Marketing Authorization Application for an Ophthalmic Product for Diabetic Macular Edema In Certain European Union Countries | 07-08-10 |
| Alimera Sciences Submits Iluvien(R) MAA for the Treatment of Diabetic Macular Edema | 07-08-10 |
| Groton Biosystems and Announce A Collaboration To Facilitate Automated Bioreactor Data Collection And Feedback Control With Reporting, Visualization, And Analysis | 07-08-10 |
| SurModics Inc. Signs License Agreement with Clinuvel | 07-08-10 |
| Los Alamos National Laboratory and Biomagnetics Diagnostics Corporation to Collaborate on Development of Revolutionary TB Diagnostic Tool | 07-08-10 |
| Biotica Technology Limited Consolidates Leadership in Polyketide Therapeutics and Extends Platform | 07-08-10 |
| Idera Pharmaceuticals, Inc. Announces Issuance of New Patents for Its Toll-like Receptor-Targeted Compounds | 07-08-10 |
| RegeneRx Biopharmaceuticals, Inc. Awarded Australian Patent for New TB4 Applications | 07-08-10 |
| ImmunoCellular Therapeutics, Ltd Appoints Two New Members to Scientific Advisory Board | 07-08-10 |
| Medidata Solutions, Inc. to Present at Events in July | 07-08-10 |
| DFine Announces Close of $36 Million Funding | 07-07-10 |
| Winston Pharmaceuticals, Inc. Submits NDA for CIVANEX?? (Civamide Cream) for Treatment of Osteoarthritis | 07-07-10 |
| Dynavax Technologies Corporation Initiates First Human Trial in Universal Flu Vaccine Program | 07-07-10 |
| Tekmira Pharmaceuticals Corporation's Partner Alnylam Pharmaceuticals Initiates Dosing in a Phase 1 Clinical Trial of ALN-TTR01 | 07-07-10 |
| Nile Therapeutics, Inc. Completes Dosing of Phase II Study | 07-07-10 |
| Winston Laboratories, Inc. Submits NDA for CIVANEX?? (Civamide Cream) for Treatment of Osteoarthritis | 07-07-10 |
| FDA Approves Beech Tree Labs, Inc.'s Oral Herpes IND Application | 07-07-10 |
| Nymox Pharmaceutical Reports Positive New Clinical Trial Data on Improvement in Key Symptom in Patients on NX-1207 Drug for Prostate Enlargement | 07-07-10 |
| Oragenics, Inc. Announces Entering into Agreement to Provide $2.0MM Equity Financing, Which Includes the Conversion of $1.0MM Unsecured Note into Equity and Additional $2.0MM Unsecured Revolving Line of Credit | 07-07-10 |
| Proximagen Neuroscience plc Enters Into A Collaboration Agreement With The National Institutes of Health (NIH) For A Phase II Clinical Trial On Naluzotan
| 07-07-10 |
| NOXXON Pharma AG to Initiate Phase Ib Clinical Trial of MCP-1 Inhibitor NOX-E36 | 07-07-10 |
| Sylentis Completes Phase I Trial with SYL040012 to Treat Elevated Intraocular Pressure and Glaucoma | 07-07-10 |
| Reprogrammed Herpes Virus Given Systemically Before Anti-vascular Drug Shrinks Distant Sarcomas, Cincinnati Children's Hospital Medical Center Study | 07-07-10 |
| Ambrilia Biopharma Inc. Provides Bi-Weekly Update on Its Status | 07-07-10 |
| BioTime Announces Passing of Board Director | 07-07-10 |
| Millipore Corporation Expands Chromatography Offering With Launch of ProRes(TM)-S Media | 07-07-10 |
| Alnylam Pharmaceuticals Initiates Dosing in Phase I Clinical Study of ALN-TTR01 in Patients with Transthyretin-Mediated Amyloidosis (ATTR) | 07-07-10 |
| Maxygen, Inc. Release: Perseid Achieves Second Preclinical Milestone Under Collaboration with Astellas Pharma Inc. for CTLA-4 Program | 07-07-10 |
| Aquapharm and Albany Molecular Research, Inc. (AMRI) Enter into a Novel Marine Chemistry Collaboration | 07-07-10 |
| PolyMedix Inc. Receives National Institutes of Health (NIH) Grant to Develop New Antimicrobials for the Treatment of Malaria | 07-07-10 |
| Applied BioCode, Inc. and Receive $2.8 Million National Institutes of Health (NIH) Grant to Pursue Multiplex Testing Platform | 07-07-10 |
| Pulmo BioTech Announces Attendance at | 07-06-10 |
| AlloCure Inc. Names Chief Executive Officer | 07-06-10 |
| Fougera Announces First Generic Approval of Adapalene Cream 0.1% (Rx), Equivalent to Differin(R) | 07-06-10 |
| Dyax Corp. Announces Marketing Authorization Application for DX-88 (ecallantide) Validated by European Medicines Evaluation Agency | 07-06-10 |
| Aastrom Biosciences, Inc. to Pursue Phase 3 Clinical Program in CLI | 07-06-10 |
| Capstone Therapeutics Announces Continuation of AZX100 Phase 2 Clinical Trial in Dermal Scarring Following Shoulder Surgery | 07-06-10 |
| Biothera Release: Combination of Imprime PGG and Erbitux Doubles the Therapeutic Response in Colorectal Cancer Patients in Phase Ib/IIa Trial | 07-06-10 |
| Curis, Inc. Achieves Phase I Milestone Under Hsp90 Collaboration with Debiopharm | 07-06-10 |
| Pharming Group And Sign Manufacturing Agreement For The Drug Substance Of Ruconest(TM) | 07-06-10 |
| Quintiles, Inc. Announces Clinical Research Partnership with the | 07-06-10 |
| Angeion Corporation Receives Fast Track and Orphan Drug Product Designations from FDA for its Lead Therapeutic, BB3 | 07-06-10 |
| Genentech Release: Second Phase III Study Showed Avastin-Containing Regimen Helped Women With Ovarian Cancer Live Longer Without Their Disease Getting Worse | 07-06-10 |
| Gardner Denver, Inc. Acquires ILMVAC GmbH | 07-06-10 |
| Accelrys Inc. Completes Merger With Symyx Technologies, Inc. | 07-06-10 |
| Applied DNA Sciences, Inc. and Sign Agreement to Jointly Market Security Technologies | 07-06-10 |
| Furiex Pharmaceuticals, Inc. Announces Issuance of U.S. Patent for Dapoxetine Method of Treatment | 07-06-10 |
| Spectrum Pharmaceuticals, Inc. Announces Results of Annual Meeting of Shareholders | 07-06-10 |
| EU Backs Nycomed's Daxas In Deadly Lung Disease; Drug Approval Could Spur IPO | 07-06-10 |
| Bacterin International, Inc. Appoints Three New Members to Its Board of Directors | 07-01-10 |
| Anne-Marie Masquelier Appointed as Global Medical Research Director at Cegedim Strategic Data (CSD) | 07-01-10 |
| RNA Therapeutics Expert Joins Kylin Therapeutics, Inc.'s Scientific Advisory Board | 07-01-10 |
| The Judge Group, Inc. Continues Investment in NYC | 07-01-10 |
| Purdue Pharma L.P. Receives FDA Approval for Butrans(TM) (buprenorphine) Transdermal System CIII | 07-01-10 |
| Skyline Solar Appoints Thomas Rohrs CEO | 07-01-10 |
| BioAlliance Pharma: Acyclovir Lauriad(R): European Registration File Submission Planned for Mid-2011 | 07-01-10 |
| Chelsea Therapeutics, Inc. Reports Positive Interim Analysis of Phase II Trial of Droxidopa in Fibromyalgia | 07-01-10 |
| Shionogi & Co., Ltd. Announces Reorganization of US Operations, New Leadership; New CEO Named | 07-01-10 |
| Corcept Therapeutics Inc. Completes Enrollment in Phase 3 Cushing's Syndrome Study -- Data Announcement Anticipated by Year End | 07-01-10 |
| Prasco Laboratories to Market Authorized Generic of ZEGERID(R) | 07-01-10 |
| Sun Pharmaceutical Industries Ltd Announces Launch of Generic Exelon(R) in US | 07-01-10 |
| MedAptus Awarded United States Patent for Technology to Process and Reconcile Professional and Technical Charges | 07-01-10 |
| Rexahn Pharmaceuticals, Inc. Closes $10 Million in Registered Direct Offering | 07-01-10 |
| Shire plc: Data Presented at the European Working Group on Gaucher Disease Demonstrate Continuous Improvements in Bone Mineral Density for VPRIV(R) (Velaglucerase Alfa) Through 69 Months | 07-01-10 |
| Columbia Laboratories, Inc. Stockholders Approve Sale of Progesterone Assets to Watson Pharmaceuticals, Inc. | 07-01-10 |
| Watson Pharmaceuticals, Inc. Confirms Columbia Laboratories, Inc. Shareholder Approval of Proposed Acquisition of Progesterone-related Assets | 07-01-10 |
| Euthymics Bioscience, Inc. and DOV Pharmaceutical Announce Merger Agreement | 07-01-10 |
| Bacterin International, Inc. Completes Merger and $7.5 Million Raise | 07-01-10 |
| Sanofi-Aventis (France) and Juvenile Diabetes Research Foundation Form Partnership to Improve Therapies, Work Toward Cure for Type 1 Diabetes | 07-01-10 |
| Roche and IBM Corporation Collaborate to Develop Nanopore-Based DNA Sequencing Technology | 07-01-10 |
| Eisai Inc. to Market Arena Pharmaceuticals, Inc.'s Lorcaserin for Obesity and Weight Management in U.S. Following FDA Approval | 07-01-10 |
| Endo Pharmaceuticals Completes Next Step in Regulatory Process for FORTESTA(TM) for Men With Low Testosterone | 07-01-10 |
| Phase III Study Shows Novartis Corporation Drug Afinitor(R) More Than Doubles Time Without Tumor Growth in Advanced Pancreatic NET Patients | 07-01-10 |
| Advanced Life Sciences Holdings, Inc. Submits Updated Special Protocol Assessment to FDA for Restanza in Community Acquired Bacterial Pneumonia | 07-01-10 |
| Eiger Biopharma Announces New HCV Synergy Data | 07-01-10 |
| Exelixis, Inc. Announces Appointment of New CEO, | 06-30-10 |
| Santarus Inc. Announces Launch of Prescription ZEGERID Authorized Generic and Company Restructuring Including a Workforce Reduction of Approximately 37%, or 120 Employees | 07-01-10 |
| Chelsea Therapeutics, Inc. Achieves Target Enrollment in Phase III Trial of Northera in Neurogenic Orthostatic Hypotension
| 06-30-10 |
| Biogen Idec, Inc. (Massachusetts) Names Exelixis, Inc.'s CEO | 06-30-10 |
| Cannabis Science Inc. Begins Expansion of Production and Research at
| 06-30-10 |
| ADVENTRX Pharmaceuticals Inc. Announces 9-Month Stability Data Results for ANX-530 | 06-30-10 |
| Northwest Biotherapeutics: Expert Available to Discuss the Emergence of Personalized Vaccines with Unprecedented Efficacy Made from One's Own Cancer Cells | 06-30-10 |
| SuperGen, Inc. Release: Dacogen(R) (Decitabine) for Injection Phase III AML Results Announced | 06-30-10 |
| BioSante Pharmaceuticals, Inc. Announces Positive Clinical Results in Pill-Plus(TM) Oral Contraceptive Study | 06-30-10 |
| Study Results Presented at Highlight Cerus Corporation' Progress Toward Improving the Safety of Platelets, Plasma and Red Blood Cells | 06-30-10 |
| Industry Veteran Appointed Chief Executive Officer of OpGen, Inc. | 06-30-10 |
| Sanofi-Aventis (France)'s Zentiva CEO To Step Down | 06-30-10 |
| Eisai Inc. Announces Results of Phase III Study of Dacogen(R) (Decitabine) for Injection in Acute Myeloid Leukemia (AML) | 06-30-10 |
| SuperGen, Inc. Drug Fails in Late-Stage Blood Cancer Trial | 06-30-10 |
| Sanofi-Aventis (France) In Talks With Covance Inc. To Sell 2 Research Sites; Sale Would entail the Transfer of Around 300 Employees | 06-30-10 |
| $5 Million Debt Deal for Dicerna Pharmaceuticals | 06-30-10 |
| Genzyme Corporation Warns of Drug Supply Disruptions as Company Struggles With Limited Inventory | 06-30-10 |
| Alimera Sciences Submits Iluvien(R) NDA to the FDA for the Treatment of Diabetic Macular Edema | 06-29-10 |
| AEterna Zentaris Receives Positive Scientific Advice from the European Medicines Evaluation Agency for its Phase 3 Trial with Perifosine in Colorectal Cancer | 06-29-10 |
| Warner Chilcott, PLC Announces Receipt of Paragraph IV Certification Notice | 06-29-10 |
| pSivida Corp Announces Submission of NDA to FDA for an Ophthalmic Product for Diabetic Macular Edema | 06-29-10 |
| SV Life Sciences Raises Over US $523 Million for Fifth Fund, SV Life Sciences Fund V | 06-29-10 |
| EpiCept Corporation Files New Drug Application for Ceplene in AML | 06-29-10 |
| Astellas Pharma Inc. Announces Oral Presentation of SGLT2 Inhibitor Detailing Safety and Efficacy in Patients With Type 2 Diabetes at the American Diabetes Association Meeting | 06-29-10 |
| Eli Lilly and Company's Effient Tied in Study to Higher Rate of Cancer Risk Than Plavix | 06-29-10 |
| Novartis AG Cannot Push through Alcon Laboratories, Inc. Merger, Says Legal Advisor | 06-29-10 |
| ESHRE: Researchers Discover Why Some Women Are Sub-fertile | 06-29-10 |
| Inovio Pharmaceuticals (Formerly Known as Inovio Biomedical Corporation)??? Novel Gene Immunoadjuvant Significantly Improves DNA Vaccine Immune Responses in Non-Human Primates | 06-29-10 |
| AMAG Pharmaceuticals, Inc. and Takeda Pharmaceutical Co. Ltd. Announce Acceptance of Submission of Feraheme(R) Marketing Authorization Application to the European Medicines Evaluation Agency | 06-29-10 |
| Alnylam Pharmaceuticals Obtains Approvals to Initiate Phase I Study with ALN-TTR01 in Patients with TTR-Mediated Amyloidosis (ATTR) | 06-29-10 |
| Mirna Therapeutics, Inc. Publishes Data Demonstrating In Vivo Proof of Concept for miR-34a microRNA Replacement Therapy in Cancer | 06-29-10 |
| Zymeworks Closes $3.2 Million Round of Financing and Announces the Addition of to Its Board of Directors | 06-29-10 |
| Fred Walder Joins Fluidigm Corporation as Chief Business Officer | 06-29-10 |
| Merck & Co., Inc. Release: Investigational BRINAVESS(R) (vernakalant) for Infusion Recommended for Approval by the in the for the Rapid Conversion of Recent Onset Atrial Fibrillation | 06-28-10 |
| Tolerx, Inc. Presents Baseline Data from DEFEND-1 Study Validating C-Peptide as Critical Clinical Measure for New-Onset Type 1 Diabetes | 06-28-10 |
| Tolerx, Inc. Presents Baseline Data from DEFEND-1 Study Validating C-Peptide as Critical Clinical Measure for New-Onset Type 1 Diabetes | 06-28-10 |
| Analyst: Roche May Drop Taspoglutide Diabetes Drug | 06-28-10 |
| Analyst: Roche May Drop Taspoglutide Diabetes Drug | 06-28-10 |
| Boehringer Ingelheim Corporation Announces Pivotal Phase III Data Showing Linagliptin Reduced Blood Sugar Compared to Placebo in People With Type 2 Diabetes | 06-28-10 |
| Biodel Inc.: Final Results of Phase 3 Study of VIAject(R) vs. Regular Human Insulin in Patients with Type 2 Diabetes Presented at American Diabetes Association Annual Meeting | 06-28-10 |
| Cancer Vaccine Maker Dendreon Corporation Can't Meet Demand | 06-28-10 |
| New Bristol-Myers Squibb Company, AstraZeneca PLC Diabetes Drug, Dapagliflozin Effective in Study | 06-28-10 |
| Novartis AG Needs Alcon Laboratories, Inc. Directors' OK for Buyout Says Advisor | 06-28-10 |
| Jury Orders Merck & Co., Inc. to Pay $8 Million Fosamax Damages | 06-28-10 |
| Johnson & Johnson's Fort Washington Facility to Stay Closed | 06-28-10 |
| NOXXON Pharma AG Announces CEO Dr. Frank Morich will Leave Company | 06-28-10 |
| Rivertop Renewables Announces James Stoppert as Chief Executive Officer | 06-28-10 |
| Shire Pharmaceuticals Braced for US Study into Heart Risks of Attention Deficit Drug | 06-28-10 |
| AEterna Zentaris Announces Collaboration with Almac Diagnostics to Develop Therapy and Companion Diagnostic in Cancer | 06-28-10 |
| American Diabetes Association/The Lancet Symposium Will Highlight Study Showing AFREZZA(TM) Provides Comparable Glycemic Control with Less Weight Gain and Hypoglycemia than Standard Care | 06-25-10 |
| UCB Group And Immunomedics, Inc. Epratuzumab Data From Phase IIB EMBLEM(TM) Study Presented at 9th International Congress on Systemic Lupus Erythematosis | 06-25-10 |
| Archimedes, Inc. Receives Positive Opinion for PecFent(R) for the Treatment of Breakthrough Cancer Pain | 06-25-10 |
| MannKind Corporation/Symposium Will Highlight Study Showing AFREZZA(TM) Provides Comparable Glycemic Control with Less Weight Gain and Hypoglycemia than Standard Care | 06-25-10 |
| Celgene International S??rl Release: REVLIMID(R) Granted Approval for Treatment of Relapsed or Refractory Multiple Myeloma in Japan | 06-25-10 |
| Human Genome Sciences, Inc. Announces Presentation of Additional Phase 3 SLE Study Results for BENLYSTA(R) (Belimumab) at International Congress on SLE | 06-25-10 |
| Amarantus MA Announces Collaboration With Pioneer Valley Life Sciences Institute | 06-25-10 |
| PharPoint Research Expands Wilmington, NC Office | 06-25-10 |
| ClinTec GmbH CEO & President, named Ernst & Young LLP Scottish Entrepreneur of the Year | 06-25-10 |
| Vyteris, Inc. to Present at New York 2010 | 06-25-10 |
| Investigational BRINAVESS(TM) (vernakalant) for Infusion Recommended for Approval by the in the for the Rapid Conversion of Recent Onset Atrial Fibrillation | 06-25-10 |
| Corcept Therapeutics Inc. Nears Completion of Enrollment in Phase 3 Cushing's Syndrome Study -- Data Announcement Anticipated by Year End | 06-25-10 |
| DeviceSpace Showcases Medical Device and Diagnostics Companies | 06-25-10 |
| European Concludes Re-Examination Of Basilea Pharmaceutica's Ceftobiprole; Confirms Negative Opinion | 06-25-10 |
| Avraham Pharmaceuticals Ltd. Receives Orphan Medicinal Product Designation for Tivozanib for the Treatment of Renal Cell Carcinoma by the European Medicines Evaluation Agency | 06-24-10 |
| Helix Biopharma Announces Positive Phase II Pharmacokinetic Findings for Topical Interferon Alpha-2b in Patients With Low-Grade Cervical Lesions | 06-24-10 |
| Ceapro Inc. Board is Re-elected at AGM | 06-24-10 |
| Theratechnologies Inc. Announces Publication of Combined Tesamorelin Phase 3 Results in | 06-24-10 |
| OXiGENE Announces Clinical Data From FACT Study to be Presented at the Congress
| 06-24-10 |
| Radient Pharmaceuticals Strategic Partner Jaiva Technologies Plans to Submit Application for Phase II Human Clinical Trials for Non-Small Cell Lung Carcinoma; Advancing Commercialization of RPC's CIT(TM) Cancer Vaccine in India | 06-24-10 |
| Pharming Group Receives Positive Opinion From European Medicines Evaluation Agency On Rhucin | 06-24-10 |
| Orexigen Therapeutics, Inc. Announces Date of FDA Advisory Committee Review of Contrave(R) for the Treatment of Obesity | 06-24-10 |
| Watson Pharmaceuticals, Inc. Receives Tentative FDA Approval for Fentanyl Buccal Tablets | 06-24-10 |
| EVSO: New Breakthrough Increases Solar Cell Conversion Efficiency to 66% | 06-24-10 |
| Senomyx, Inc. Signs Letter Agreement With Regarding Potential Collaboration Related To The Discovery, Development, And Commercialization Of New Sweet Flavor Ingredients | 06-24-10 |
| Entelos, Inc. Agrees to Expanded License Terms with Pfizer Inc. | 06-24-10 |
| International Stem Cell Corporation Announces New Patent Issuance Under License Agreement | 06-24-10 |
| BioSante Pharmaceuticals, Inc. Closes $15 Million Registered Direct Offering to Fund LibiGel(R) for Female Sexual Dysfunction | 06-24-10 |
| ACM Global Central Laboratory to Provide Guidance on Increasing Operational Efficiencies in Central Labs | 06-24-10 |
| AVEO Pharmaceuticals, Inc. Receives Orphan Medicinal Product Designation for Tivozanib for the Treatment of Renal Cell Carcinoma by the European Medicines Evaluation Agency | 06-24-10 |
| Merck & Co., Inc. to Initiate Proof-of-Concept Study of Posaconazole for Chronic Chagas Disease, Recognized by World Health Organization as One of the World??'s Neglected Tropical Diseases | 06-24-10 |
| Midatech Group Expands Collaboration with MonoSolRx LLC to Deliver Peptides Utilizing Nanotechnology and PharmFilm(R) Drug Delivery Technology | 06-24-10 |
| NexMed Receives Screening Acceptance Letter from Health Canada for Vitaros(R) | 06-23-10 |
| MAP Pharmaceuticals, Inc. Presents Analyses Showing LEVADEX Effective when Administered at Various Times in Migraine Cycle and in Patients with Concomitant Asthma | 06-23-10 |
| AstraZeneca PLC and Targacept, Inc. Initiate Phase 3 Clinical Development of TC-5214 as an Adjunct Treatment for Major Depressive Disorder | 06-23-10 |
| Mersana Therapeutics, Inc. Initiates Phase 1 Clinical Trial for XMT-1107 in Oncology | 06-23-10 |
| Actavis Names New Chief Executive | 06-23-10 |
| Anthera Pharmaceuticals, Inc. Enrolls First Patients in Pivotal Varespladib Phase 3 Clinical Study | 06-23-10 |
| Scil Proteins GmbH Affilin(R) Drug Discovery Platform Validated in Animals | 06-23-10 |
| Alnylam Pharmaceuticals Presents New Data on RNAi Applications in Biotherapeutics Manufacturing | 06-23-10 |
| BioPharm Asia, Inc. Introduces | 06-23-10 |
| AstraZeneca AB and Targacept, Inc. Initiate Phase 3 Clinical Development of TC-5214 as an Adjunct Treatment for Major Depressive Disorder | 06-23-10 |
| Advaxis, Inc. Completes Dosing of Vanguard Patient Group in Phase II Cervical Dysplasia Clinical Trial | 06-23-10 |
| SIGA Technologies, Inc. Completes Fourth Successful Human Safety Clinical Trial | 06-23-10 |
| International Stem Cell Corporation Names to Board of Directors | 06-22-10 |
| SG Biofuels Expands Operations with Addition of to Executive Team | 06-22-10 |
| Cell>Point Submits Investigational New Drug Application for Phase 1b/2 Trial of 99mTc-EC-G in Assessing Coronary Artery Disease | 06-22-10 |
| QLT Inc. Announces Final Results From Its RADICAL Study Evaluating Verteporfin PDT (Visudyne(R)) Combination Therapy in Exudative AMD | 06-22-10 |
| Nereus Pharmaceuticals, Inc. Completes Enrollment of Phase 2 ADVANCE Clinical Trial of Plinabulin in Non-Small Cell Lung Cancer | 06-22-10 |
| Telik, Inc. Announces Publication of a Case Report of a Sustained Hematologic Response in Myelodysplastic Syndrome Following an Abbreviated Exposure to Oral Telintra(R) (Ezatiostat HCl) | 06-22-10 |
| IntelGenx Corp. Reports on Meeting With FDA | 06-22-10 |
| World Congress on Gastrointestinal Cancer: New Study Indicates Significant Improvement in Progression-Free Survival for Patients with Advanced Pancreatic Neuroendocrine Tumors | 06-22-10 |
| Inovio Pharmaceuticals (Formerly Known as Inovio Biomedical Corporation) Optimized DNA Vaccine Demonstrates Significant Advantages in Non-Human Primates Compared to Leading Viral Vector Based Vaccine | 06-22-10 |
| Ipsen: Encouraging results of GuidAge(R), large scale European trial conducted in the prevention of Alzheimer??'s Dementia | 06-22-10 |
| QLT Inc. Eye Drug, Lucentis Cuts Need to Revisit Doctor | 06-22-10 |
| AEterna Zentaris Receives $12 Million on Closing of Registered Direct Offering | 06-22-10 |
| Consolidated Pharmaceutical Fined $250,000 for Shutting the Door on Hazardous Materials | 06-22-10 |
| Jackson Lab Could be Start of Biomedical Hub in Collier, FL Officials Say | 06-22-10 |
| Bristol-Myers Squibb Company Release: Dapagliflozin as Monotherapy Demonstrated Improved Glycemic Control in Treatment-Na??ve Adults with Type 2 Diabetes | 06-22-10 |
| Nuon Therapeutics Inc. Announces Results of Studies Confirming the Uric Acid Lowering Activity of Tranilast | 06-22-10 |
| GW Pharmaceuticals Announces Uk Launch Of World??'s First Prescription Cannabis-Medicine
| 06-21-10 |
| Affymax, Inc. and Takeda Global Research & Development Center, Inc. Announce Phase 3 Trials Meet Primary Endpoints for Investigational Drug, Hematide(TM)/peginesatide, to Treat Anemia in Chronic Renal Failure With Some Differences Noted in Secondary Analyses | 06-21-10 |
| Rhythm Pharmaceuticals: RM-493 Reverses Obesity and Insulin Resistance in Obese Primates | 06-21-10 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Comments on June 18th FDA Advisory Committee Meeting | 06-21-10 |
| Star Scientific , Inc. Files Second Application With FDA for Approval of a Modified Risk Tobacco Product | 06-21-10 |
| Cerenis Therapeutics, Inc. to Present Clinical Proof-of-Concept Results for CER-627 program (niacin/aspirin combinations) at the European Atherosclerosis Society Congress June 20-23 | 06-21-10 |
| The Gamida Cell Ltd.-Teva Pharmaceutical Industries Limited Joint Venture Receives FDA Fast Track Designation for StemEx(R) for Leukemia and Lymphoma | 06-21-10 |
| BioSante Pharmaceuticals, Inc. Says FDA Advisory Committee Recommendation Against Flibanserin has No Impact on LibiGel(R) | 06-21-10 |
| GTx, Inc. Announces Ostarine Increased Lean Body Mass and Leg Press Strength in Head to Head Clinical Study | 06-21-10 |
| ZIOPHARM Oncology, Inc. Provides Guidance on Planned Pivotal Phase III Study of Palifosfamide in Metastatic Soft Tissue Sarcoma | 06-21-10 |
| Alkermes Announces Notification of Tentative Alkermes Advisory Committee Meeting to Review VIVITROL(R) for Opioid Dependence | 06-18-10 |
| Ipsen??'s Partner Roche Announces Amendment of the Trial Protocols for the Taspoglutide Phase III Programme | 06-18-10 |
| Pfizer Inc. Faces Trials in 200 Suits Over Hormone-Drugs | 06-18-10 |
| NexBio, Inc. and Weill Cornell Medical College Publish Preclinical Study Showing DAS181 (Fludase(R)*) Anti-Influenza Drug Inhibits Parainfluenza Virus | 06-18-10 |
| Tengion Inc. Presents New Data Supporting its Organ Regeneration Platform(TM) at 8th Annual Meeting of the International Society for Stem Cell Research | 06-18-10 |
| ChemoCentryx, Inc. Reports Positive Phase I Study Results for CCX354 at the Annual European Congress of Rheumatology (EULAR) | 06-18-10 |
| Amylin Pharmaceuticals, Inc. to Present New Data and Insights From the Company's Diabetes | 06-18-10 |
| UCB, Inc.'s Neupro(R) (Rotigotine Transdermal System) Significantly Improved Wellbeing and Daily Activities Impaired Due to Limb Pain Associated With Restless Legs Syndrome | 06-18-10 |
| Innovacell Includes First Patients in a Phase IIb Study for Its Cell Therapy Product urocell(R) , for the Treatment of Stress Urinary Incontinence | 06-18-10 |
| Positive Phase 2 Data on RDEA594, Ardea Biosciences, Inc.'s Lead Product Candidate for the Treatment of Hyperuricemia and Gout, Presented at the | 06-18-10 |
| Teva Pharmaceutical Industries Limited Announces Completion of $2.5 Billion of Senior Notes Offering | 06-18-10 |
| Novogen Limited Restructures Australian Management Team and Marshall Edwards, Inc. Appoints CFO | 06-18-10 |
| BioSante Pharmaceuticals, Inc. To Present LibiGel(R) Safety Update at Annual Meeting | 06-18-10 |
| Histogen, Inc.: Human Embryonic-Like Extracellular Matrix Significantly Inhibits Tumor Growth and Cancer Cell Proliferation | 06-18-10 |
| Biotechnology Industry Organization (BIO) Lauds Passage of Small Business Early-Stage Investment Program | 06-18-10 |
| NASDAQ Sets July 22, 2010 for Repros Therapeutics Inc. Hearing to Appeal NASDAQ Delisting Notice | 06-18-10 |
| Agilent Technologies Inc. Launches Bio-Inert LC to Characterize Large Biomolecules, New Biological Entities | 06-18-10 |
| Lonnel Coats Appointed President & Chief Executive Officer of Eisai Inc. | 06-18-10 |
| Lars Fruergaard J??rgensen Joins the ZymoGenetics, Inc. Board of Directors | 06-18-10 |
| Pluripotent Stem Cell Leader to Receive 26th Annual Kyoto Prize in "Advanced Technology" | 06-18-10 |
| Alkermes Announces Notification of Tentative FDA Advisory Committee Meeting to Review VIVITROL(R) for Opioid Dependence | 06-18-10 |
| Roche??'s Partner Roche Announces Amendment of the Trial Protocols for the Taspoglutide Phase III Programme | 06-18-10 |
| Proteo Inc./ Proteo Biotech AG: Will Be Tested at the | 06-18-10 |
| Genzyme Corporation Announces Accelerated Share Repurchase | 06-18-10 |
| Arena Pharmaceuticals, Inc.'s Lorcaserin to Be Featured in Presentations at the American Diabetes Association's 70th Scientific Sessions | 06-17-10 |
| Sun Pharmaceutical Industries Ltd Announces FDA Approval for Generic Keppra(R) Injection | 06-17-10 |
| FerroKin BioSciences Completes $12 Million Financing | 06-17-10 |
| Inspire Pharmaceuticals, Inc. Release: New Data Presented At Conference Highlight Potential for Denufosol to Provide Benefit to Adolescent Cystic Fibrosis Patients and Patients on Minimal Pharmacotherapies | 06-17-10 |
| UV Flu Technologies Inc. Announces Placement of ViraTech UV-400 Air Purifiers at Major Boston Hospitals | 06-16-10 |
| Ann Arbor's Grand River Interactive, NanoBio Corporation Plan to Add 80 Jobs | 06-17-10 |
| Innothera to Close Celbridge Pharma Plant in Ireland; Jobs to Go | 06-17-10 |
| PRA International, Inc. Opens Phase I Unit in Budapest | 06-16-10 |
| DURECT Corporation Says Pain Drug Meets 1 of 2 Study Goals | 06-17-10 |
| Sun Pharmaceutical Industries Ltd Announces Approval for Generic Keppra(R) Injection | 06-17-10 |
| BSD Medical Reports Hyperthermia Use with Particle Therapy Highlighted at Meeting | 06-17-10 |
| Kaplan EduNeering and Drug Information Association Form Strategic Alliance | 06-17-10 |
| Cyntellect, Inc. Appoints as CEO | 06-17-10 |
| OBI-1 Developed by Ipsen and Inspiration Biopharmaceuticals Has Obtained a Positive Opinion for the Orphan Drug Status in Europe | 06-17-10 |
